Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Aissaoui
Reimbursement Decisions in Oncology Drugs: An International Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Time to Reimbursement for Oncology Drugs in EU5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn292 - Cancer Drugs in Germany: Hta Decisions of New and Innovative Oncology Drugs in Germany – An Analysis Using the Prismaccess® Database
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php242 - An Analysis of the Timelines Throughout the Reimbursement Pathway for Drugs in Ireland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases
Medical Decision Making
Health Policy
An Analysis of Drivers of International Investment Decisions in South Africa
Reimbursement Approval of Oncology Drugs in Canada Supported by a Data Package Lacking Phase III Trial Data
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn305 - Nice and the Cancer Drugs Fund – Can Observational Evidence Inform Funding Decisions in Oncology?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn299 - A Review of Appraisal Timelines in Oncology: Does Reimbursement Through the Cancer Drugs Fund (Cdf) Delay Patient Access?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Balancing Early Access With Uncertainties in Evidence for Drugs Authorized by Prospective Case Series - Systematic Review of Reimbursement Decisions
British Journal of Clinical Pharmacology
Pharmacology
